slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,117
Current window 30,301-30,330
Pages 1,371
Rows per page 30
Component
30,301-30,330 of 41,117
02
Kering | Mergers and Acquisitions Presentation Deck | 15 slidesKering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
02
Kymera | Investor Presentation Deck | 60 slidesKymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
07
The slide uses a Gantt-style chart to show the progression of various drug programs (IRAK4, IRAKIMiD, STAT3, MDM2, etc.) through discovery, IND enabling, and clinical phases.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
18
The slide compares cytokine inhibition efficacy in Healthy Subjects (MAD3), AD patients, and HS patients using two different stimulation methods (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
25
Data compares 'All HS Patients' vs 'Moderate to Severe' subgroups. Includes error bars representing standard error of the mean or 80% confidence intervals.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
27
The charts demonstrate a shift from higher severity scores (orange/red) to lower severity scores (blue/black) over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
38
Data presented for Cycle 1; DL4 shows mean values for n=2 patients.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
39
Includes a disclaimer/footnote regarding patient population and MYD88 mutation status.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
45
Clinical trial safety data table showing patient counts and percentages for specific adverse events.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
49
DL1-3 refers to dose levels 1-3. PK = Pharmacokinetics, PD = Pharmacodynamics, DLT = Dose-Limiting Toxicity, SAE = Serious Adverse Event.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
50
Includes a disclaimer regarding EBITDA growth exclusion.Limoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Action1 hit
13
Part 2 of 2 on transparency initiatives.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations Beat · KPIs and TargetsLoop · Cost Of Inaction1 hit
15
The slide uses a three-column layout to present objectives/results, programs/initiatives, and stakeholder engagement.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations Beat · Key MessagesLoop · So What Cascade1 hit
23
The slide uses a grid-like layout to categorize philanthropic efforts into three main pillars.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations 1 hit
06
The slide provides a breakdown of portfolio characteristics including fair value, debt yield, and equity ownership statistics.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Solution1 hit
07
LMM stands for Lower Middle Market.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Solution1 hit
09
The slide uses a pie chart for transaction types and a choropleth map for geographic distribution.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Solution1 hit
12
The slide provides key metrics for the Private Loan portfolio as of March 31, 2023.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses grouped bar charts to compare cost vs fair value across investment vintages.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
19
The chart uses a custom benchmark grouping (MAIN vs Top 10%, Top Quartile, Middle Quartile, Average, Bottom Quartile).Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
23
The slide uses three bar charts to demonstrate that MAIN outperforms peers in dividend coverage, specifically contrasting against those with high dividend growth.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
24
The slide uses two bar charts to compare MAIN against peer benchmarks (Top 10%, Top Quartile, Middle Quartile, Peer Group Average, Bottom Quartile).Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
25
Includes two tables comparing GAAP ROE and two bar charts showing historic average GAAP ROE and implied credit gains.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
26
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
27
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
28
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
29
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · Market Size1 hit
33
The chart shows significant outperformance of MAIN compared to S&P 500, Russell 2000, KBW Regional Bank Index, and S&P BDC Index.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
38
The table compares Main Street Capital Corporation against various peer group segments (Average, Top 10%, Top/Middle/Bottom Quartiles) across multiple financial metrics.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
39
The table highlights Main Street's performance metrics against 14 other BDCs over a 6-year period (2017-2022).Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit